Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
-17.2%/yr
Annual compound
5Y CAGR
-1.3%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $48.44M | -16.9% |
| 2024 | $58.26M | -23.2% |
| 2023 | $75.86M | -11.2% |
| 2022 | $85.45M | +19.5% |
| 2021 | $71.53M | +38.5% |
| 2020 | $51.66M | +349.2% |
| 2019 | $11.50M | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |